Skip to main content
. 2017 Nov 2;7(12):e00794. doi: 10.1002/brb3.794

Table 3.

Primary and secondary outcomes at test occasions (ITT and PP)

Baseline (ITT/PP) Pretest (ITT/PP) Midtest (ITT/PP) Posttest (ITT/PP) p‐value (ITT) p‐value (PP)
Primary outcome
6MWT (incl. outlier)a 349 ± 90/349 ± 90 366 ± 74/366 ± 74 420 ± 93/420 ± 93 441 ± 123/466 ± 137 .116 .119
6MWT (excl. outlier)b 376(284;447)/376(241;447) 361(290;446)/361(289;446) 393(321;490)/393(302;490) 398(320;508)/438(298;509) .160 .058
Secondary outcomes
SF‐36; physical functioningb 45(30;60)/45(10;60) 38(33;60)/38(25;60) 50(20;85)/50(10;85) 55(20;90)/70(45;93) .375 .157
SF‐36; role limitations due to physical healthb 50(0;100)/50(0;100) 25(0;50)/25(0;50) 75(25;100)/75(0;100) 75(0;100)/100(0;100) .322 .151
SF‐36; role limitations due to emotional problemsb 100(100;100)/100(33;100) 100(100;100)/100(100;100) 100(67;100)/100(33;100) 100(100;100)/100(33;100) .261 .392
SF‐36; energy/fatigueb 55(46;65)/55(35;65) 45(30;70)/45(20;70) 65(40;90)/65(20;90) 65(35;85)/70(45;90) .664 .431
SF‐36; emotional well‐beingb 76(68;88)/76(52;88) 84(64;96)/84(44;96) 88(68;96)/88(36;96) 84(68;88)/84(48;88) .774 .924
SF‐36; social functioningb 75(50;100)/75(25;100) 88(63;100)/88(50;100) 100(50;100)/100(50;100) 100(50;100)/100(63;100) .636 .392
SF‐36; painb 68(45;100)/68(33;100) 58(45;90)/58(45;90) 78(45;90)/78(23;90) 78(45;100)/90(58;100) .943 .310
SF‐36; general healthb 51(30;70)/51(5;70) 50(25;60)/50(15;60) 45(35;65)/45(20;65) 50(30;60)/55(25;68) .909 .259
FSSb 4.3(3.5;5.9)/4.3(2.8;5.9) 5.6(4.2;5.9)/5.6(3.3;5.9) 4.4(3.9;5.9)/4.4(3.1;5.9) 4.9(3.0;5.9)/4.2(2.6;4.9) .303 .238
BBSb 41(29;45)/41(25;45) 37(33;48)/37(28;48) 43(37;45)/43(30;45) 45(43;49)/47(43;52) .021c .121
CT‐SIB; eyes open, firm surfaceb .52(.35;.93)/.52(.35;93) .73(.28;.81)/73(.28;.81) .60(.37;.76)/.60(.37;.76) .54(.31;.94)/.54(.31;.98) .766 .782
CT‐SIB; eyes closed, firm surfaceb 1.44(1.17;1.94)/1.44(1.17;1.94) 1.32(1.27;1.80)/1.32(1.27;1.80) 1.69(.82;2.21)/1.69(.82;2.21) 1.48(.78;2.08)/1.35(.78;1.74) .996 .996
CT‐SIB; eyes open, foam surfaceb 1.29(.90;3.42)/1.29(.90;3.42) 1.40(.88;1.61)/1.40(.88;1.61) 1.02(.84;1.44)/1.02(.84;1.44) 1.04(.71;1.18)/.91(.71;1.08) .205 .468
CT‐SIB; eyes closed, foam surfaceb NP NP NP NP NP NP
PST; overallb .90(.40;1.80)/.90(.40;1.80) .70(.40;1.30)/.70(.40;1.30) .50(.40;.70)/.50(.40;.70) .50(.40;.70)/.50(.40;.60) .014d .023d
Fitnessb NA 118(96;127)/118(96;127) 104(99;128)/104(97;115) 102(98;124)/102(94;120) .438 .449

ITT, intention‐to‐treat analysis; PP, per protocol analysis; 6MWT, 6‐min walk test (m); SF‐36, short form (36) health survey (score); FSS, fatigue severity scale (score); BBS, Berg balance scale (score); CT‐SIB, clinical test of sensory integration and balance (index); PST, postural stability test (index); NA, not applicable; NP, not possible to complete. Fitness (average heart rate in the fifth minute of moderate‐intensity walking).

a

Mean ± 1.96 SD.

b

Median (25th; 75th percentile).

c

p‐values are for analyses of variance between more than two repeated measurements. Post hoc baseline–posttest; p adjusted = .043, all other comparisons; p adjusted ≥ .104).

Post hoc all comparisons; p adjusted ≥ .178.

d

Post hoc all comparisons; p adjusted ≥ .120.